Results 181 to 190 of about 491,626 (323)

Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma. [PDF]

open access: yesAnn Hematol
Maraglino AME   +6 more
europepmc   +1 more source

T-cell differentiation stage block bias confers hypermethylation and mediastinal preference in T-cell lymphoblastic lymphoma. [PDF]

open access: yesClin Transl Med
Wang J   +10 more
europepmc   +1 more source

Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer Registry

open access: yesCancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Background Bladder cancer (BC) is one of the most common cancers and many patients will experience long‐term survival. Non‐urothelial second primary cancers (SPC) relatively frequently occur in the population of BC survivors. Methods Czech National Cancer Registry was the principal data source for this study.
Tomas Buchler   +5 more
wiley   +1 more source

A Case Report of HIV‐Associated Pituitary Lymphoma and Review of the Literature

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Primary saddle region tumors are the most commonly pituitary adenomas: They account for more than 90% of all saddle region tumors. Primary central nervous system lymphoma (PCNSL) lesions are relatively rare and are usually found around the ventricles. Reports of PCNSL lesions located in the saddle region are even rarer.
Yahui Cui   +4 more
wiley   +1 more source

Cutaneous Involvement in a Case of T-lymphoblastic Lymphoma: A Rare Presentation. [PDF]

open access: yesIndian Dermatol Online J
Kowe P   +4 more
europepmc   +1 more source

Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color

open access: yes
International Journal of Dermatology, Volume 65, Issue 1, Page 157-159, January 2026.
Eric McMullen   +10 more
wiley   +1 more source

Acute Myeloid Leukemia Secondary to Radiation Therapy for Rectal Cancer: A Case Report

open access: yesCancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Therapy‐related AML (t‐AML) is a subtype of acute myeloid leukemia (AML) that arises in the bone marrow and primarily affects white blood cells. It is associated with prior exposure to cytotoxic agents, including chemotherapy and radiotherapy. The risk of the disease increases with age and treatment intensity.
Ahmad Alkhaledi   +4 more
wiley   +1 more source

Supplementary Figure 3 from MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16

open access: gold, 2023
Qian Dong   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy